CRL vs TVRD · rev $2.00B vs rev $2.6M
Charles River Laboratories (CRL) versus Tvardi Therapeutics, Inc. (TVRD) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported TVRD revenue for 2025-03-31 was $2.6M. Net income was -$4.9M. TVRD currently screens at market cap $0.
CRL currently screens at market cap $7.78B. TVRD currently screens at market cap $0.
Not investment advice. Open the CRL and TVRD stock pages for the full models.
Not investment advice.